Company intelligence / Profile preview

MM Molecular Pharma Consulting

Ownership: Private
Development stage: Commercial

Overview

MM Molecular Pharma Consulting LLC is a life sciences consulting firm led by Mary Mader. The company provides strategic and scientific advisory services to pharmaceutical, biotech, and related organizations. It leverages deep industry experience from leadership roles at companies such as Medicines for Malaria Venture, Relay Therapeutics, Eli Lilly, and Indiana Biosciences Research Institute. There is no evidence that the company develops its own therapeutic pipeline.

Industry: Consulting

Beyond the preview

Go deeper on MM Molecular Pharma Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MM Molecular Pharma Consulting.

Explore the full profile